Dr David Bunka

Chief Technical Officer

David holds a Ph.D. in Molecular Biology and has spent nearly 20 years developing nucleic acid aptamers against a wide variety of targets including: small molecules (antibiotics, food contaminants, chemotherapeutics), disease associated proteins, several cancer associated cell-lines, viruses and tissue biopsies. This has been facilitated through the use of high throughput automated aptamer selection methods.

David has built up a solid international reputation in the field and has authored several peer reviewed research articles, invited review articles and a book chapter on aptamer based therapeutics. He has also given many guest seminars covering aptamer-based applications, at top universities and international conferences.